113 related articles for article (PubMed ID: 9603633)
1. Imipenem resistance in aerobic gram-negative bacteria.
Modakkas EM; Sanyal SC
J Chemother; 1998 Apr; 10(2):97-101. PubMed ID: 9603633
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of newer broad spectrum beta-lactam antibiotics against enterobacteriaceae and non-fermenters: a report from Austrian intensive care units. Austrian Carbapenem Susceptibility Surveillance Group.
Krause R; Mittermayer H; Feierl G; Allerberger F; Wendelin I; Hirschl A; Reisinger EC
Wien Klin Wochenschr; 1999 Jul; 111(14):549-54. PubMed ID: 10467641
[TBL] [Abstract][Full Text] [Related]
3. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
[TBL] [Abstract][Full Text] [Related]
4. Utility of serial rectal swab cultures for detection of ceftazidime- and imipenem-resistant gram-negative bacilli from patients in the intensive care unit.
Arbo MD; Hariharan R; Nathan C; Barefoot L; Weinstein RA; Snydman DR
Eur J Clin Microbiol Infect Dis; 1998 Oct; 17(10):727-30. PubMed ID: 9865988
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
Bastianini L; Sposini T; Bartoli A; Marconi P
Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
[TBL] [Abstract][Full Text] [Related]
6. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Valenza G; Seifert H; Decker-Burgard S; Laeuffer J; Morrissey I; Mutters R;
Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
[TBL] [Abstract][Full Text] [Related]
7. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
Chen MJ; Wang H;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of imipenem against 1386 clinical isolates.
Belobraydic KA; Qadri SM
Methods Find Exp Clin Pharmacol; 1986 Nov; 8(11):675-8. PubMed ID: 3468319
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
Klietmann W; Focht J; Nösner K
Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
[TBL] [Abstract][Full Text] [Related]
10. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
Xiao QZ; Su DH; Jiang JH; Zhong NS
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Itokazu GS; Quinn JP; Bell-Dixon C; Kahan FM; Weinstein RA
Clin Infect Dis; 1996 Oct; 23(4):779-84. PubMed ID: 8909844
[TBL] [Abstract][Full Text] [Related]
12. Outbreak caused by two multi-resistant Acinetobacter baumannii clones in a burns unit: emergence of resistance to imipenem.
Lyytikäinen O; Köljalg S; Härmä M; Vuopio-Varkila J
J Hosp Infect; 1995 Sep; 31(1):41-54. PubMed ID: 7499820
[TBL] [Abstract][Full Text] [Related]
13. Activity of imipenem on aerobic bacteria.
Acar JF; Goldstein FW; Kitzis MD; Gutmann L
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():37-45. PubMed ID: 6421793
[TBL] [Abstract][Full Text] [Related]
14. Changes in bacterial isolates from burn wounds and their antibiograms: a 20-year study (1986-2005).
Guggenheim M; Zbinden R; Handschin AE; Gohritz A; Altintas MA; Giovanoli P
Burns; 2009 Jun; 35(4):553-60. PubMed ID: 19167827
[TBL] [Abstract][Full Text] [Related]
15. Emerging resistance to carbapenems in a tertiary care hospital in north India.
Gupta E; Mohanty S; Sood S; Dhawan B; Das BK; Kapil A
Indian J Med Res; 2006 Jul; 124(1):95-8. PubMed ID: 16926463
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of piperacillin/tazobactam versus other broad-spectrum antibiotics against nosocomial gram-negative pathogens isolated from burn patients.
Mokaddas E; Rotimi VO; Sanyal SC
J Chemother; 1998 Jun; 10(3):208-14. PubMed ID: 9669645
[TBL] [Abstract][Full Text] [Related]
18. Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
Dong SX; Wang JT; Chang SC
J Microbiol Immunol Infect; 2012 Dec; 45(6):459-64. PubMed ID: 23102796
[TBL] [Abstract][Full Text] [Related]
19. Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).
Sader HS; Farrell DJ; Flamm RK; Jones RN
J Infect; 2014 Sep; 69(3):266-77. PubMed ID: 24780763
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups.
Hanberger H; Garcia-Rodriguez JA; Gobernado M; Goossens H; Nilsson LE; Struelens MJ
JAMA; 1999 Jan; 281(1):67-71. PubMed ID: 9892453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
